Clinical Trials Using Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine
Clinical trials are research studies that involve people. The clinical trials on this list are studying Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors
This trial will comprehensively evaluate the human papillomavirus (HPV) vaccine in cancer survivors between 9 and 26 years of age by (1) determining the prevalence of HPV vaccine initiation among young cancer survivors, and (2) determining the immune response to and safety / tolerability of the quadrivalent HPV vaccine in young cancer survivors.
Location: 5 locations